• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Abbott’s sales increased 4% in Q2, slight revisions made to guidance

cafead

Administrator
Staff member
  • cafead   Jul 18, 2024 at 11:02: PM
via Abbott Laboratories reported a 4% increase in quarterly sales, totalling $10.4 billion.

The company released its latest earnings report Thursday and subsequently revised its full-year financial guidance.

article source